Filing Details

Accession Number:
0001209191-20-063907
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-16 19:25:28
Reporting Period:
2020-12-14
Accepted Time:
2020-12-16 19:25:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661998 Homology Medicines Inc. FIXX Pharmaceutical Preparations (2834) 473468154
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664281 Kush Parmar 501 2Nd Street, Suite 350
San Francisco CA 94107
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-14 151,138 $13.06 5,163,346 No 4 S Indirect See footnote
Common Stock Disposition 2020-12-14 328,862 $11.88 4,834,484 No 4 S Indirect See footnote
Common Stock Disposition 2020-12-14 6,297 $13.06 215,138 No 4 S Indirect See footnote
Common Stock Disposition 2020-12-14 13,703 $11.88 201,435 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The shares are held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. The Reporting Person is an affiliate of Partners IV and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  2. The shares are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. The Reporting Person is an affiliate of Partners IV and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.